Länssjukhuset Sundsvall-Härnösand är ett av tre sjukhus inom Region Västernorrland, som i sin tur ingår i Norra sjukvårdsregionen. Länssjukhuset bedriver verksamhet främst i Sundsvall, men även i Härnösand, under gemensam sjukhusadministration.

During the past decade, Sundsvalls Sjukhus conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sundsvalls Sjukhus" #1 sponsor was "Hoffmann-La Roche" with 1 trials, followed by "Molnlycke Health Care AB" with 1 trials sponsored, "Niaz Ahmed" with 1 trials sponsored, "Pfizer" with 1 trials sponsored and "University Medical Center Groningen" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sundsvalls Sjukhus" #1 collaborator was "Dutch Cancer Society" with 1 trials as a collaborator, "Karolinska University Hospital" with 1 trials as a collaborator, "Leiden University Medical Center" with 1 trials as a collaborator and "Uppsala University Hospital" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Sundsvalls Sjukhus" are "Acute Ischaemic Stroke" (1 trials), "Arthritis, Rheumatoid" (1 trials), "Early Breast Cancer" (1 trials), "Rectal Cancer" (1 trials) and "Wounds and Injuries" (1 trials). Many other conditions were trialed in "Sundsvalls Sjukhus" in a lesser frequency.

Most popular intervention types in "Sundsvalls Sjukhus" are "Drug" (3 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Acrylic adhesive dressing" (1 trials), "CP-690,550" (1 trials), "Endocrine Therapy of Physician's Choice" (1 trials), "Giredestrant" (1 trials) and "Imatinib 400mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sundsvalls Sjukhus" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Sundsvalls Sjukhus". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Sundsvalls Sjukhus, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Sundsvalls Sjukhus, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".